Luc Thomas
enseignant-chercheur
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (18)
Year:
2026
Year:
2026
Year:
2026
Background Melanoma accounts for more than 75% of skin cancer‐related mortality. Dermatoscopy is an evidence‐based technique for earlier detection, yet differentiating melanocytic lesions remains challenging. Sub‐UV reflectance dermatoscopy (sUVRD) uses purple light (405 nm) to visualise chromophore distribution in the skin. Objectives This study aimed to evaluate whether the visibility of pigment network in melanomas is reduced under sub‐UV reflectance dermatoscopy (sUVRD) compared to polarised dermatoscopy (PD), and to assess this as a potential diagnostic clue for malignancy in melanocytic lesions. Methods We retrospectively analysed routinely collected medical images of pathology‐confirmed non‐acral non‐facial melanomas and clinically/dermatoscopically typical nevi in consecutive adult patients seen at Centre Léon Berard from 13 July 2023 to 28 October 2024. Only quality images displaying a pigmented network in at least one quadrant in PD were included. Three blinded raters with varying dermatoscopic experience (10+, 5+, < 1 years) assessed whether pigment network visibility under sUVRD was reduced or equal compared to PD. Results Among 39 patients (M/F ratio 1.29), 20 melanomas and 20 nevi were analysed. Pigment network visibility under sUVRD was significantly more reduced in melanomas versus nevi (60% vs. 20%; Chi‐square p = 0.024; OR = 6; sensitivity 0.6; specificity 0.8; PPV 0.75; NPV 0.67; Fragility index 2). Inter‐rater concordance was moderate (Fleiss' kappa 0.41). Conclusions In this preliminary study, reduced pigment network visibility under sUVRD compared to PD showed promise as a clue to differentiate melanomas from nevi displaying dermatoscopic network, with an odds ratio superior to most common melanoma criteria. Further validation on larger datasets with pathology‐confirmed lesions and standardised imaging conditions is required.
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Background: Melanoma constitutes an increasing global health burden. In the light of a growing shortage of dermatologists in several countries, primary care has emerged as an optimal setting for skin cancer screening. Historically, in France, skin cancer detection was typically managed by dermatologists, while general practitioners (GPs) were barely involved. In 2021, the Association of French GPs practicing Dermoscopy was created to address this gap by promoting and legitimizing dermoscopy practice among primary care physicians. Objectives: To assess the number of melanomas detected by dermoscopy-trained GPs, three years after the association’s foundation and to compare the melanomas histopathological characteristics to those documented in existing literature. Methods: A survey was shared via Google® Form with all the members of the association’s Facebook® account between November 26, 2024 to December 26, 2024. Results: A total of 85 general practitioners responded the survey. They reported the detection of 266 melanomas, corresponding to approximately 1.6 per year of dermoscopy practice in median (mean: 2,9). Thirty nine point five percent of detected melanomas (105/266) were in situ, while only 22,4% (36/161) had a Breslow thickness above 1mm, which constitute a substantial improvement compared to previously reported data on GP-detected melanomas. Conclusions : Empowerment of primary care medicine through dermoscopy learning appears to be a promising way to overcome the relative shortage of diagnostic offer observed in several countries. Integrating skin cancer screening into GPs practice may contribute to melanoma early detection and support ongoing efforts to lower melanoma mortality.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (12)
Martyna Sławińska
University Clinical Centre
Grazyna Kaminska-Winciorek
Full Prof. M.D.Ph.D.,MBA, scientific position; Head of the Skin Cancer and Melanoma Team in MSCNRIO, Gliwice Branch; medical consultant
Maria Sklodowska-Curie National Research Institute of Oncology
Claus Garbe
Professor of Dermatology
Eberhard Karls Universität Tübingen
Michał Kunc
Pathologist
Medical University of Gdansk
Jakub Karol Żółkiewicz
Medical University of Gdansk
Aimilios Lallas
Associate Professor
Aristotle University of Thessaloniki
Evelyne Harkemanne
UCLouvain
Grant McArthur
Lorenzo Galli Chair of Melanoma and Skin Cancers
University of Melbourne
Samy Belkaïd
Université Claude Bernard Lyon 1
Paolo Antonio Ascierto
Full Professor
Università degli Studi di Napoli Federico II
allan halpern
Chief of Service
Memorial Sloan Kettering Cancer Center
Giovanni Pellacani
Full Professor
Università degli Studi di Roma La Sapienza
Make your next move.
Prepare your application
Review drafts before you send them.